Clinical Trials Logo

Clinical Trial Summary

The overall aim was to evaluate the efficacy of PiB-specific phages for the treatment of refractory constipation through clinical studies, primarily for the publication of scientific papers and to guide the development of phage therapies. The purpose of this study will be subdivided into three aspects from three aspects: target exposure level, target occupation, and functional effects after acting on the target, including:1) The distribution of PIB phage in the intestine of patients with refractory constipation;2) The killing effect of PIB phage on PIB bacteria in refractory constipation patients;And 3) therapeutic effect of PIB phage on patients with refractory constipation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05973721
Study type Interventional
Source Shanghai 10th People's Hospital
Contact Hongliang Tian, Dr
Phone +86-18917688267
Email tianhl@tongji.edu.cn
Status Recruiting
Phase N/A
Start date July 1, 2023
Completion date October 1, 2023